Milk's hidden trail: can a glass of milk reveal gut bacteria in the blood?
NCT ID NCT06944002
First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time
Summary
Researchers at Erasmus Medical Center are testing whether drinking milk can make bacteria from the gut appear in the blood. Healthy volunteers will avoid dairy for ten days, then drink 700 ml of milk daily for a week. The team will compare bacterial DNA in blood and stool samples to see if the blood microbiome mirrors the gut microbiome. This study could help develop a simpler way to monitor gut health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Milk product (dietary supplement)
- What this could lead to
- If it works, this could show that blood samples can reflect gut bacteria, offering a less invasive way to study the gut microbiome.
- What could go wrong
- This is a small, early study with only 9 participants, so the results may not apply broadly. The detection of bacterial DNA in blood could be inconsistent or hard to interpret.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
9 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-65 years * 18.5 =\< BMI \< 25 kg/m2 * All genders included * Not be lactose intolerant * Willing to consume milk Exclusion Criteria: * Regularly used medications such as antibiotics, steroids, beta blockers, and adrenergic- stimulating agents (self-report) * Regular use of prebiotic and/or probiotics apart from yogurt and young soft cheese (self-report) * Antibiotic intake in the previous months (self-report) * Daily consumption of more than 10 cigarettes (self-report) * Chronic diseases including type 2 diabetes, hypertension, fatty liver disease, cancer, or autoimmune disease (self-report) * Internal diseases, including those of the gastrointestinal tract, lung, heart, vasculature, liver, and kidney (self-report) * Eating disorder or unconventional eating habits (self-report) * Participation in another study (self-report) * Women: pregnancy and breastfeeding (self-report)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erasmus MC - Department of Gastroenterology and Hepatology
Rotterdam, 3015 GD, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The effects of external nasal dilator strips on sleep and cardiovascular health
- A pharmacokinetic study of NTI164 in healthy adult volunteers
- Genetic determinants of Exercise-Induced muscle damage (POLYGENDOMUS) / déterminants génétiques des dommages musculaires induits par l'Exercice (POLYGENDOMUS)
- Can a simple injection timing reduce bleeding after skin cancer surgery?
- Can Land-Based teachings shape psychedelic therapy training?
- Can a new oral drug pass early safety tests?